X-group (possible homology)

3892 Transhydrogeanse domain II

Ligands and drugs

99
Member domains
17
with ligand contacts (≤ 4 Å)
17.2% of members
18
with DrugDomain annotations
18.2% of members
6
with a DrugBank compound
6.1% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

3
Proteins with classified ligands
5
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Hydrocarbons10.048×not tested
Lipids and lipid-like molecules20.36.07×not tested
Benzenoids10.24.62×not tested
Nucleosides, nucleotides, and analogues20.82.45×not tested
Homogeneous metal compounds21.51.38×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03461NAPNicotinamide adenine dinucleotide phosphate4
DB09092——2
DB00157—NADH1

Most frequently bound compounds

PDB ligandNameDomains in contact
PC11,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE10
D12DODECANE4
NAPNADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE4
BENBENZAMIDINE2
HGmetalMERCURY (II) ION2
PKZPalmitoyl-CoA2
OLC(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate1